Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

Alcon IPO: Swiss eye care company reports sales of $707 mil., up 8%, in its first quarter as an independent entity following its March 20 initial public offering of 76.7 mil. shares of common stock at $33 each - which raised net proceeds of roughly $2.4 bil. (1"The Gray Sheet" March 4, 2002, p. 22). Surgical unit revenue of $338 mil. was ahead 4%, anchored by AcrySof intraocular lens sales of $102 mil...
Advertisement

Related Content

Sunrise Technologies
Sunrise Technologies
Alcon To Keep R&D Focus After Spin-Off From Parent Nestle By April Via IPO
Alcon To Keep R&D Focus After Spin-Off From Parent Nestle By April Via IPO
Biocompatibles Lens Unit Divestiture Could Ripen Firm For Abbott Purchase
Advertisement
UsernamePublicRestriction

Register

MT016540

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel